AR038856A1 - USE OF ESTRIOL DIESTER BIOGEN PRODUCTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES - Google Patents

USE OF ESTRIOL DIESTER BIOGEN PRODUCTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

Info

Publication number
AR038856A1
AR038856A1 ARP030100644A AR038856A1 AR 038856 A1 AR038856 A1 AR 038856A1 AR P030100644 A ARP030100644 A AR P030100644A AR 038856 A1 AR038856 A1 AR 038856A1
Authority
AR
Argentina
Prior art keywords
estriol
treatment
biogen
diester
products
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Walter Elger
Sybille Beier
Keyserlingk Harald Von
Frank Dahlke
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR038856A1 publication Critical patent/AR038856A1/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: El uso de un éster de estriol de la fórmula general (1) donde R es un grupo alquilo o fenilo C1-10 lineal o ramificado, para la fabricación de un medicamento caracterizado porque es para el tratamiento de una enfermedad autoinmune en un mamífero. Reivindicación 2: el uso de acuerdo con la reivindicación 1, caracterizado porque dicho éster de estriol es 3,17-propionato de estriol o 3,17-dihexanoato de estriol. Reivindicación 3: El uso de acuerdo con la reivindicación 1, caracterizado porque dicho éster de estriol es 3,17beta-di-n-hexanoiloxi-1,3,5(10)-estratrieno-16alfa-ol. Reivindicación 11: El uso de un éster de estriol de la fórmula general (1) caracterizado porque R es un grupo alquilo o fenilo de C1-10 lineal o ramificado, para la fabricación de un medicamento para proporcionar un nivel de estriol en sangre como el que se observa en una mujer durante las últimas etapas del embarazo.Claim 1: The use of an estriol ester of the general formula (1) wherein R is a linear or branched C1-10 alkyl or phenyl group, for the manufacture of a medicament characterized in that it is for the treatment of an autoimmune disease in a mammal. Claim 2: the use according to claim 1, characterized in that said estriol ester is 3.17-estriol propionate or 3.17-estriol dihexanoate. Claim 3: The use according to claim 1, characterized in that said estriol ester is 3.17 beta-di-n-hexanoyloxy-1,3,5 (10) -estratriene-16 alpha-ol. Claim 11: The use of an estriol ester of the general formula (1) characterized in that R is a linear or branched C1-10 alkyl or phenyl group, for the manufacture of a medicament for providing a blood estriol level such as which is observed in a woman during the last stages of pregnancy.

ARP030100644 2002-02-27 2003-02-27 USE OF ESTRIOL DIESTER BIOGEN PRODUCTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES AR038856A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35972602P 2002-02-27 2002-02-27

Publications (1)

Publication Number Publication Date
AR038856A1 true AR038856A1 (en) 2005-01-26

Family

ID=38812741

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100644 AR038856A1 (en) 2002-02-27 2003-02-27 USE OF ESTRIOL DIESTER BIOGEN PRODUCTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

Country Status (4)

Country Link
AR (1) AR038856A1 (en)
PE (1) PE20030882A1 (en)
TW (1) TW200402298A (en)
UY (1) UY27690A1 (en)

Also Published As

Publication number Publication date
UY27690A1 (en) 2003-09-30
TW200402298A (en) 2004-02-16
PE20030882A1 (en) 2003-10-20

Similar Documents

Publication Publication Date Title
AR025444A1 (en) DERIVATIVES OF SULFONIL-CARBOXAMIDE, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS
ECSP066670A (en) PRODUCTS FLORFENICOL WITH BETTER SOLUBILITY IN WATER
AR051577A1 (en) ETER DERIVATIVES REPLACED BY HEXAFLUORISOPROPANOL
ES2176343T3 (en) HEALING COMPOSITIONS OF TREATMENT OF WOUNDS CAUSED BY THE ACNE THAT CONTAIN A PYRUVAN, AN ANTIOXIDANT AND A MIXTURE OF FATTY ACIDS.
GT200000190A (en) PROCEDURE FOR OBTAINING 1,2,3,4-TETRAHYDROCHINOLINES-4-CARBOXYAMIN-2-SUBSTITUTED.
CO5611162A2 (en) METHODS TO PREVENT REPRODUCTIVE DISEASES IN VACCINE LIVESTOCK
ATE475416T1 (en) FAT ALCOHOLS AND FATTY ACID ESTERS FOR THE TREATMENT OF INFLAMMATION
AR061622A1 (en) ESTERES OF THE DOCOSAHEXAENOIC ACID (DHA), IN PARTICULAR THE DOCOSAHEXAENOATO OF PIRIDIN-3-IL-METHYL, METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE TREATMENT AND PREVENTION OF CARDIOVASULAR DISEASES
ECSP056006A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES
AR098899A1 (en) COMPOSITIONS FOR ORAL CARE AND METHODS
PA8542901A1 (en) USE OF (Z) -2-CIANO-3-HYDROXI-BUT-2-ENOIC ACID- (4-TRIFLUOROMETILFENIL) -AMIDA TO TREAT MULTIPLE SCLEROSIS
PA8514901A1 (en) METABOLITES AGONISTAS / ANTAGONISTAS DE ESTROGENO
CY1110644T1 (en) 5,6,7-Trihydroxyheptanoic acid and its analogues for the treatment of ophthalmic diseases related to hypercapillary and angiogenic diseases
ATE453409T1 (en) ANTI-INFLAMMATORY FAT ALCOHOLS AND FATTY ACID ESTERS AS ANTIGEN CARRIERS
BR0112245B1 (en) 4-Alkoxy-cyclohexane-1-amino-carboxylic acid ester
ES2151716T3 (en) PEPTIDED DERIVATIVES.
HN2003000040A (en) ACIDS 3- (IMIDAZOLIL) -2-AMINOPROPANOICS
AR037766A1 (en) TRIAROMATIC COMPOUNDS ANALOGS OF VITAMIN D, ITS USE, PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT INCLUDE THEM AND COSMETIC USE OF SUCH COSMETIC COMPOSITIONS
AR038856A1 (en) USE OF ESTRIOL DIESTER BIOGEN PRODUCTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
RU2011121605A (en) DEVICE FOR MANUFACTURE OF DISPOSABLE FLOOR HOLDERS
AR063894A1 (en) USE OF AN INDAZOLMETOXIALCANOIC ACID TO PREPARE A PHARMACEUTICAL COMPOSITION
BR0108087A (en) Method and compositions for the treatment of an inflammatory disease
PA8509601A1 (en) "PIRAZOLO [4,3, e] NOVEDOUS REPLACED DIAZEPINS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, ITS USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM
GT200100015A (en) ETERES OF CALCIUM DICARBOXYLATE, METHODS FOR THE PREPARATION AND TREATMENT OF VASCULAR DISEASES AND DIABETESCON THE SAME.
PA8636801A1 (en) PROCESSES FOR THE PREPARATION OF ALKYL OR BENCILIC ESTERS OF ACID 2-CIANO-3-NAFTALEN-1-IL-ACRYLIC

Legal Events

Date Code Title Description
FA Abandonment or withdrawal